Background & Aims The evolving epidemiologic patterns of inflammatory bowel disease
(IBD) throughout the world, in conjunction with advances in therapeutic treatments, may …

Background & Aims A comprehensive knowledge of the natural history of ulcerative colitis
(UC) helps understand disease evolution, identify poor prognostic markers and impact of …

Background & Aims The inflammatory bowel diseases (IBDs) are chronic diseases that often
require surgery. However, the risk of requirement of surgery over time has not been well …

Background Ulcerative colitis (UC) is a risk factor for colorectal cancer (CRC). However,
available studies reflect older treatment and surveillance paradigms, and most have …

Introduction Crohn's disease (CD) and ulcerative colitis (UC) have a progressive course
leading to hospitalisation and surgery. The ability of existing therapies to alter disease …

Introduction Treatment possibilities have changed in inflammatory bowel disease (IBD). We
assessed changes in medical treatment and surgery over time and impact of medications on …

Objectives To better understand the real-world impact of biologic therapy in persons with
Crohn's disease (CD) and ulcerative colitis (UC), we evaluated the effect of marketplace …

The UK and China provide unique historical perspectives on the evolution of the incidence
of inflammatory bowel disease, which might provide insight into its pathogenesis. Historical …

1.1. Aim The overarching aim of ECCO is to improve the care of patients with IBD through
the development of guidelines, education and research. Current evidence is fundamental in …

Abstract Background and Aims Few population-based cohort studies have assessed the
disease course of ulcerative colitis [UC] in the era of biological therapy and widespread use …